| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |